Company Filing History:
Years Active: 2012-2015
Title: Ann-Hwee Lee: Innovator in Hepatic Lipogenesis
Introduction
Ann-Hwee Lee is a notable inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of hepatic lipogenesis, particularly through his innovative methods and compositions aimed at treating dyslipidemias and steatosis disorders. With a total of 2 patents, his work has garnered attention in the scientific community.
Latest Patents
Ann-Hwee Lee's latest patents focus on methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity. The inventions provide methods and compositions for modulating the expression, processing, post-translational modification, stability, and/or activity of the XBP-1 protein. These methods are crucial for treating dyslipidemias and steatosis disorders. Additionally, the patents include methods for identifying compounds that can modulate the expression and activity of XBP-1 protein or related molecules in the signal transduction pathway.
Career Highlights
Throughout his career, Ann-Hwee Lee has worked with prestigious institutions such as Harvard College and Cornell University. His research has significantly advanced the understanding of lipid metabolism and its implications for health.
Collaborations
Ann-Hwee Lee has collaborated with notable figures in his field, including Laurie H. Glimcher, who is recognized for her contributions to immunology and cancer research.
Conclusion
Ann-Hwee Lee's innovative work in hepatic lipogenesis and his collaborations with esteemed institutions and individuals highlight his impact on the field. His patents represent a significant step forward in the treatment of metabolic disorders.